Recently, Gallardo et al. found that diffuse large B-cell lymphoma (DLBCL) patients with high hnRNP K expression suffered poor clinical outcomes compared with patients with low hnRNP K expression [22]. The gene discussed is HNRNPK; the disease is diffuse large B-cell lymphoma.